| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5810956 | Medical Hypotheses | 2015 | 5 Pages |
Abstract
The most promising antiangiogenic drug seems to be Thalidomide, but other drugs such as Sirolimus, VEGF pathway inhibitors, Interferon or Matrix Metalloproteinase (MMP) Inhibitors could serve the purpose just as well. Even Propranolol could prove useful in this sense as suggested by some recent researches on retinopathy of prematurity and tumour biology.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Developmental Biology
Authors
Giacomo Colletti, Pietro Dalmonte, Laura Moneghini, Daris Ferrari, Fabiana Allevi,